On May 15 – May 18, 2022, this poster was on display at ISPOR 2022.
What is the Objective of this Poster?
- Results provide insights into real-world trends in use of biologics for treatment of PsA.
- Patient use of biologics increased steadily over the observation period with decreased use of some therapies being replaced with increased use of other therapies.
- Given multiple approved indications for many of these biologics, further analyses would be helpful to try to delineate reason for biologic use for patients with multiple indications.
Register to view this poster now!